Published in J Am Coll Cardiol on October 20, 2009
Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ Res (2011) 3.72
Women and men with stable coronary artery disease have similar clinical outcomes: insights from the international prospective CLARIFY registry. Eur Heart J (2012) 2.30
Gender differences in coronary heart disease. Neth Heart J (2010) 2.16
Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med (2014) 2.12
Relation between objective measures of atopy and myocardial infarction in the United States. J Allergy Clin Immunol (2012) 1.98
Sex differences in platelet reactivity and cardiovascular and psychological response to mental stress in patients with stable ischemic heart disease: insights from the REMIT study. J Am Coll Cardiol (2014) 1.49
Sex-Specific Associations Between Coronary Artery Plaque Extent and Risk of Major Adverse Cardiovascular Events: The CONFIRM Long-Term Registry. JACC Cardiovasc Imaging (2016) 1.46
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv (2012) 1.30
Coronary microvascular dysfunction: an update. Eur Heart J (2013) 1.28
Gender differences in the risk of coronary artery disease in iran. Iran J Public Health (2012) 1.17
Psychosocial factors in the development of heart disease in women: current research and future directions. Psychosom Med (2010) 1.13
Cardiac syndrome X and microvascular coronary dysfunction. Trends Cardiovasc Med (2012) 1.12
Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. Eur Heart J Acute Cardiovasc Care (2013) 1.12
Women and coronary artery disease. Part I: basic considerations. J Tehran Heart Cent (2011) 1.11
Myocardial ischemia in women: lessons from the NHLBI WISE study. Clin Cardiol (2012) 1.07
Coronary vasoconstrictor responses are attenuated in young women as compared with age-matched men. J Physiol (2010) 1.06
Ischemic heart disease in women: many questions, few facts. Circ Cardiovasc Qual Outcomes (2010) 1.00
Cardiovascular Disease in Women: Clinical Perspectives. Circ Res (2016) 0.92
Presentation, management, and outcomes of ischaemic heart disease in women. Nat Rev Cardiol (2013) 0.92
Sex differences in the association of Framingham Cardiac Risk Score with cognitive decline in community-dwelling elders without clinical heart disease. Psychosom Med (2011) 0.88
Serum extracellular vesicle protein levels are associated with acute coronary syndrome. Eur Heart J Acute Cardiovasc Care (2013) 0.88
Sex, Myocardial Infarction, and the Failure of Risk Scores in Women. J Womens Health (Larchmt) (2015) 0.87
Sex-based prognostic implications of nonobstructive coronary artery disease: results from the international multicenter CONFIRM study. Radiology (2014) 0.86
Cardiovascular risk score, cognitive decline, and dementia in older Mexican Americans: the role of sex and education. J Am Heart Assoc (2013) 0.86
Gallbladder gallstone disease is associated with newly diagnosed coronary artery atherosclerotic disease: a cross-sectional study. PLoS One (2013) 0.85
Population-based incidence of sudden cardiac and unexpected death before and after the 2011 earthquake and tsunami in Iwate, northeast Japan. J Am Heart Assoc (2014) 0.84
Life satisfaction and risk of chronic diseases in the European prospective investigation into cancer and nutrition (EPIC)-Germany study. PLoS One (2013) 0.84
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ (2011) 0.84
Gender differences in recovery outcomes after an early recovery symptom management intervention. Heart Lung (2011) 0.84
Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp Biol Med (Maywood) (2014) 0.84
Sex differences in the diagnostic evaluation of coronary artery disease. J Nucl Cardiol (2011) 0.83
Trends in age-standardised and age-specific mortality from ischaemic heart disease in Germany. Clin Res Cardiol (2010) 0.83
One more look at guidelines for primary and secondary prevention of cardiovascular disease in women. Arch Med Sci (2011) 0.83
Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association. Circulation (2016) 0.83
Consuming a balanced high fat diet for 16 weeks improves body composition, inflammation and vascular function parameters in obese premenopausal women. Metabolism (2014) 0.82
A multicenter, prospective study to evaluate the use of contrast stress echocardiography in early menopausal women at risk for coronary artery disease: trial design and baseline findings. J Womens Health (Larchmt) (2013) 0.81
Sex differences in inflammation during atherosclerosis. Clin Med Insights Cardiol (2015) 0.80
Sickness absence following coronary revascularisation. A national study of women and men of working age in Sweden 1994-2006. PLoS One (2012) 0.80
Developments in the invasive diagnostic-therapeutic cascade of women and men with acute coronary syndromes from 2005 to 2011: a nationwide cohort study. BMJ Open (2015) 0.80
Social Integration and Reduced Risk of Coronary Heart Disease in Women: The Role of Lifestyle Behaviors. Circ Res (2017) 0.80
Gender differences in health-related quality of life in patients undergoing coronary angiography. Open Heart (2015) 0.79
Predictive value of the corrected TIMI frame count in patients with suspected angina pectoris but no obstructive coronary artery disease at angiography. Clin Res Cardiol (2014) 0.79
Detection of coronary artery disease in postmenopausal women: the significance of integrated stress imaging tests in a 4-year prognostic study. Clin Res Cardiol (2014) 0.79
Imaging Tests, Provocative Tests, Including Exercise Testing in Women with Suspected Coronary Artery Disease. Curr Cardiovasc Risk Rep (2012) 0.78
The Challenges of Prevention, Diagnosis and Treatment of Ischemic Heart Disease in Women. Cardiovasc Drugs Ther (2015) 0.78
Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep (2015) 0.78
Strategies and methods to study female-specific cardiovascular health and disease: a guide for clinical scientists. Biol Sex Differ (2016) 0.78
Sex Difference in Coronary Endothelial Dysfunction in Apolipoprotein E Knockout Mouse: Role of NO and A2A Adenosine Receptor. Microcirculation (2015) 0.77
Acute Myocardial Infarction in a Young Lady due to Vitamin B12 Deficiency Induced Hyperhomocysteinemia. Heart Views (2015) 0.77
Coronary microvascular dysfunction: sex-specific risk, diagnosis, and therapy. Nat Rev Cardiol (2015) 0.77
Mortality trends in women and men presenting with acute coronary syndrome: insights from a 20-year registry. PLoS One (2013) 0.77
Noninvasive assessment of coronary artery disease in women: What's next? Curr Cardiol Rep (2010) 0.76
Sleep apnea and retinal signs in cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Sleep Breath (2015) 0.76
Sex Differences in Correlates of Intermediate Phenotypes and Prevalent Cardiovascular Disease in the General Population. Front Cardiovasc Med (2015) 0.76
Age- and Gender-Normalized Coronary Incidence and Mortality Risks in Primary and Secondary Prevention. Cardiol Res (2012) 0.76
Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. Physiol Genomics (2015) 0.76
Sex-related differences in prognosis after myocardial infarction: changes from 1978 to 2007. Eur J Epidemiol (2012) 0.75
Use of diagnostic coronary angiography in women and men presenting with acute myocardial infarction: a matched cohort study. BMC Cardiovasc Disord (2016) 0.75
Global Coronary Artery Plaque Area is Associated with Myocardial Hypoperfusion in Women with Non-ST Elevation Myocardial Infarction. J Womens Health (Larchmt) (2015) 0.75
Relationship between Serum Levels of Metalloproteinase-8 and Tissue Inhibitor of Metalloproteinases-1 and Exercise Test Results in Postmenopausal Women. Dis Markers (2016) 0.75
Gender Differences in Post-Traumatic Stress. Biores Open Access (2017) 0.75
Myocardial revascularization: do age and sex matter? J Thorac Dis (2016) 0.75
Increase HDL-C level over the menopausal transition is associated with greater atherosclerotic progression. J Clin Lipidol (2016) 0.75
Predictors of Health-Related Quality of Life in Patients with Co-Morbid Diabetes and Chronic Kidney Disease. PLoS One (2016) 0.75
Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention. Saudi Med J (2017) 0.75
Influence of age, gender, and race on nitric oxide release over acupuncture points-meridians. Sci Rep (2015) 0.75
Training emergency physicians in sex- and gender-based medicine: assessing attitudes of program directors and residency graduates. Biol Sex Differ (2016) 0.75
Male and female hypertrophic rat cardiac myocyte functional responses to ischemic stress and β-adrenergic challenge are different. Biol Sex Differ (2016) 0.75
The diagnosis of CAD in women: addressing the unmet need - a report from the national expert roundtable meeting. Popul Health Manag (2015) 0.75
Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in women. PLoS One (2017) 0.75
Genetic Research and Women's Heart Disease: a Primer. Curr Atheroscler Rep (2016) 0.75
Age- and gender-related differences in drug utilisation and adverse drug reaction patterns among patients in a coronary care unit. Singapore Med J (2014) 0.75
Inflammation, Atherosclerosis and Coronary Artery Disease. Clin Med Insights Cardiol (2016) 0.75
Therapy for stable angina in women. P T (2012) 0.75
Myocardial tissue deformation is reduced in subjects with coronary microvascular dysfunction but not rescued by treatment with ranolazine. Clin Cardiol (2016) 0.75
In-hospital Mortality Characteristics of Women With Acute Myocardial Infarction. J Clin Med Res (2009) 0.75
Is Needed Dobutamine Stress Echocardiography for the Detection of Coronary Artery Stenosis in Women? J Cardiovasc Ultrasound (2016) 0.75
Sex-specific factors in microvascular angina. Can J Cardiol (2014) 0.75
Noninvasive Imaging to Evaluate Women With Stable Ischemic Heart Disease. JACC Cardiovasc Imaging (2016) 0.75
Difference in Leukocyte Composition between Women before and after Menopausal Age, and Distinct Sexual Dimorphism. PLoS One (2016) 0.75
Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women? Diabetol Metab Syndr (2017) 0.75
Cardiovascular reactivity during stressful speaking tasks in Mexican-American women: effects of language use and interaction partner ethnicity. J Behav Med (2012) 0.75
Utility of Imaging in Risk Stratification of Chest Pain in Women. Curr Treat Options Cardiovasc Med (2017) 0.75
Sex differences in coronary heart disease and stroke mortality: a global assessment of the effect of ageing between 1980 and 2010. BMJ Glob Health (2017) 0.75
Stable ischemic heart disease in women: current perspectives. Int J Womens Health (2017) 0.75
Detection of non-obstructive coronary artery disease: Is post-stress diastolic dysfunction assessed by myocardial perfusion imaging a useful tool? J Nucl Cardiol (2016) 0.75
Clinical characteristics of patients with suspected cardiac chest pain and angiographically normal coronary arteries in a secondary care hospital. Neth Heart J (2017) 0.75
Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA (2003) 25.44
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA (2002) 18.43
Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med (2008) 18.34
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32
Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care (2001) 14.03
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation (2007) 11.95
Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med (2008) 11.79
Analysis of probability as an aid in the clinical diagnosis of coronary-artery disease. N Engl J Med (1979) 9.91
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr (2008) 7.91
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med (2008) 7.33
Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol (2007) 7.13
Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2006) 7.09
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99
Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N Engl J Med (1999) 6.62
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk (1996) 6.18
Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation (2000) 6.13
Methods for evaluation of retinal microvascular abnormalities associated with hypertension/sclerosis in the Atherosclerosis Risk in Communities Study. Ophthalmology (1999) 6.07
Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J (1986) 5.89
The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med (2006) 5.69
Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med (2002) 5.42
Underuse of coronary revascularization procedures in patients considered appropriate candidates for revascularization. N Engl J Med (2001) 5.29
Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis (2006) 5.20
Radiation dose to patients from cardiac diagnostic imaging. Circulation (2007) 5.10
Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials. Lancet (2002) 5.04
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation (1998) 4.89
Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med (2007) 4.64
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med (1999) 4.53
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation (2003) 4.19
Endothelial function: cardiac events. Circulation (2005) 3.80
2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2008) 3.70
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med (2006) 3.56
Deaths: final data for 1998. Natl Vital Stat Rep (2000) 3.44
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol (2006) 3.25
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. JAMA (2004) 3.17
Mortality and cardiac and vascular outcomes in extremely obese women. JAMA (2006) 3.09
Angina with "normal" coronary arteries: a changing philosophy. JAMA (2005) 2.98
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA (1991) 2.88
Trends in the incidence and survival of patients with hospitalized myocardial infarction, Olmsted County, Minnesota, 1979 to 1994. Ann Intern Med (2002) 2.87
Effect of risk factors on the mechanism of acute thrombosis and sudden coronary death in women. Circulation (1998) 2.82
Retinal arteriolar narrowing and risk of coronary heart disease in men and women. The Atherosclerosis Risk in Communities Study. JAMA (2002) 2.78
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women. J Am Coll Cardiol (2002) 2.74
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis. Arch Intern Med (2002) 2.69
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. Eur Heart J (2006) 2.67
Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation (2004) 2.67
The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol (2006) 2.64
Spontaneous coronary vasospasm in KATP mutant mice arises from a smooth muscle-extrinsic process. Circ Res (2006) 2.64
Ethnic-specific prevalence of peripheral arterial disease in the United States. Am J Prev Med (2007) 2.63
Coronary artery calcium scores and risk for cardiovascular events in women classified as "low risk" based on Framingham risk score: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med (2007) 2.62
Gender differences in the management and clinical outcome of stable angina. Circulation (2006) 2.59
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol (2006) 2.57
Prevalence of angina in women versus men: a systematic review and meta-analysis of international variations across 31 countries. Circulation (2008) 2.56
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.50
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med (2009) 2.48
Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study. J Am Coll Cardiol (2008) 2.48
Is subendocardial ischaemia present in patients with chest pain and normal coronary angiograms? A cardiovascular MR study. Eur Heart J (2007) 2.46
Favorable cardiovascular risk profile in young women and long-term risk of cardiovascular and all-cause mortality. JAMA (2004) 2.45
Seven year survival of patients with normal or near normal coronary arteriograms: a CASS registry study. J Am Coll Cardiol (1986) 2.44
Morphological predictors of arterial remodeling in coronary atherosclerosis. Circulation (2002) 2.39
Prognostic value of gated myocardial perfusion SPECT. J Nucl Cardiol (2004) 2.36
Treatment of acute myocardial infarction and 30-day mortality among women and men. N Engl J Med (2000) 2.35
A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ (2007) 2.35
Abnormal coronary vasomotion as a prognostic indicator of cardiovascular events in women: results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation (2004) 2.30
The evaluation of chest pain in women. N Engl J Med (1996) 2.24
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. Am Heart J (2001) 2.22
Age and gender distributions of coronary artery calcium detected by electron beam tomography in 35,246 adults. Am J Cardiol (2001) 2.21
Retracted Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab (2008) 2.21
Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol (1999) 2.20
Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol (2001) 2.17
Incidence and prognostic implications of stable angina pectoris among women and men. JAMA (2006) 2.16
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol (2001) 2.12
Long-term L-arginine supplementation improves small-vessel coronary endothelial function in humans. Circulation (1998) 2.08
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation. Circulation (2006) 2.03
Sex-related differences in the presentation, treatment and outcomes among patients with acute coronary syndromes: the Global Registry of Acute Coronary Events. Heart (2008) 1.98
Coronary artery calcium to predict all-cause mortality in elderly men and women. J Am Coll Cardiol (2008) 1.95
Short- and long-term prognosis after acute myocardial infarction in men versus women. Am J Cardiol (2006) 1.89
Endothelial function predicts future development of coronary artery disease: a study of women with chest pain and normal coronary angiograms. Circulation (2004) 1.81
Prognostic role of flow-mediated dilation and cardiac risk factors in post-menopausal women. J Am Coll Cardiol (2008) 1.78
Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J (2003) 1.74
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. J Am Coll Cardiol (2007) 1.69
Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol (2003) 1.68
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link! J Am Coll Cardiol (2012) 2.93
Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med (2006) 2.73
Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and in-hospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation (2008) 2.53
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med (2009) 2.48
Persistent chest pain and no obstructive coronary artery disease. JAMA (2009) 2.27
Red versus white wine as a nutritional aromatase inhibitor in premenopausal women: a pilot study. J Womens Health (Larchmt) (2011) 2.09
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Menopause (2011) 2.06
The economic burden of angina in women with suspected ischemic heart disease: results from the National Institutes of Health--National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation. Circulation (2006) 2.03
The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis. PLoS One (2015) 1.76
Comorbid depression and anxiety symptoms as predictors of cardiovascular events: results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Psychosom Med (2009) 1.70
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol (2004) 1.70
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. J Womens Health (Larchmt) (2004) 1.57
Leisure time physical activity and early atherosclerosis: the Los Angeles Atherosclerosis Study. Am J Med (2003) 1.53
Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause (2014) 1.50
Can change in high-density lipoprotein cholesterol levels reduce cardiovascular risk? Am Heart J (2004) 1.50
Effects of simvastatin on cardiac neural and electrophysiologic remodeling in rabbits with hypercholesterolemia. Heart Rhythm (2008) 1.49
Pulse pressure and adverse outcomes in women: a report from the Women's Ischemia Syndrome Evaluation (WISE). Am J Hypertens (2008) 1.42
Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med (2007) 1.41
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. JACC Cardiovasc Interv (2012) 1.30
34th Bethesda Conference: Executive summary--can atherosclerosis imaging techniques improve the detection of patients at risk for ischemic heart disease? J Am Coll Cardiol (2003) 1.22
Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women. J Womens Health (Larchmt) (2011) 1.21
Diastolic dysfunction: improved understanding using emerging imaging techniques. Am Heart J (2010) 1.17
Social networks and incident stroke among women with suspected myocardial ischemia. Psychosom Med (2008) 1.14
Association between the severity of angiographic coronary artery disease and paraoxonase gene polymorphisms in the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Am J Hum Genet (2002) 1.10
Getting guidelines correct: their evidence-based recommendations for use of nonstatins added to statins and the need for follow-up lipid testing. J Am Coll Cardiol (2015) 1.09
Gender differences in the link between depression and cardiovascular disease. Psychosom Med (2005) 1.09
Large brachial artery diameter is associated with angiographic coronary artery disease in women. Am Heart J (2002) 1.06
Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation (2002) 1.05
Global inflammation predicts cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Am Heart J (2005) 1.04
Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. Arch Gen Psychiatry (2006) 1.04
The Yentl syndrome is alive and well. Eur Heart J (2011) 1.03
Sex differences in clinical outcomes in patients with stable angina and no obstructive coronary artery disease. Am Heart J (2013) 1.02
Limitations of current cardiovascular disease risk assessment strategies in women. J Womens Health (Larchmt) (2006) 1.00
Depression is associated with cardiac symptoms, mortality risk, and hospitalization among women with suspected coronary disease: the NHLBI-sponsored WISE study. Psychosom Med (2006) 0.94
A summary of implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol (2004) 0.94
Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. J Clin Endocrinol Metab (2008) 0.93
Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study. Psychosom Med (2005) 0.91
Cardiac symptoms in women and men. JAMA Intern Med (2013) 0.90
A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause (2012) 0.90
Towards elimination of the dark-rim artifact in first-pass myocardial perfusion MRI: removing Gibbs ringing effects using optimized radial imaging. Magn Reson Med (2013) 0.90
Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC Cardiovasc Disord (2006) 0.88
New insights into ischemic heart disease in women. Cleve Clin J Med (2007) 0.88
Combining psychosocial data to improve prediction of cardiovascular disease risk factors and events: The National Heart, Lung, and Blood Institute--sponsored Women's Ischemia Syndrome Evaluation study. Psychosom Med (2012) 0.87
Sex hormones and the QT interval: a review. J Womens Health (Larchmt) (2012) 0.86
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. Cardiovasc Diagn Ther (2013) 0.86
Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol (2005) 0.86
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation. J Transl Med (2008) 0.86
Progression of carotid intima-media thickness and plasma antioxidants: the Los Angeles Atherosclerosis Study. Arterioscler Thromb Vasc Biol (2003) 0.85
Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ (2011) 0.84
Validation of the accuracy of pretest and exercise test scores in women with a low prevalence of coronary disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. Am Heart J (2004) 0.84
New insights into ischemic heart disease in women. J Calif Dent Assoc (2008) 0.84
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. Am Heart J (2005) 0.84
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: results from the NHLBI WISE Study. Clin Cardiol (2002) 0.83
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). J Womens Health (Larchmt) (2008) 0.82
Isoflavone supplementation and endothelial function in menopausal women. Clin Endocrinol (Oxf) (2002) 0.82
Association of anti-oxidized LDL and candidate genes with severity of coronary stenosis in the Women's Ischemia Syndrome Evaluation study. J Lipid Res (2011) 0.81
Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study. Open Cardiovasc Med J (2012) 0.77
Reply: To PMID 22954239. J Am Coll Cardiol (2013) 0.75
Assessing mature technology: what is the effect of high-quality risk stratification evidence with exercise echocardiography and single-photon emission computed tomography imaging? J Am Coll Cardiol (2006) 0.75
Therapy for stable angina in women. P T (2012) 0.75
Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study. Menopause (2016) 0.75
A report card on remodeling cardiac rehabilitation into secondary prevention programs: not making the grade. J Cardiopulm Rehabil (2002) 0.75
Menopausal hormone therapy and national time trends in mortality: cautions regarding causal inference. Menopause (2017) 0.75
Task force 10: training in preventive cardiovascular medicine. J Am Coll Cardiol (2008) 0.75
Female-specific factors for IHD: across the reproductive lifespan. Curr Atheroscler Rep (2015) 0.75